Funded Startups in Cork
Recent Cork rounds span from 2020-03-25 (ToDesktop, $200K) to 2026-06-29 (Neurobell, $6M), with the most recent year showing multiple large disclosed checks.
Recent Cork rounds span from 2020-03-25 (ToDesktop, $200K) to 2026-06-29 (Neurobell, $6M), with the most recent year showing multiple large disclosed checks. The largest disclosed round is Amarenco’s $212M on 2025-04-15, which dwarfs the next-largest disclosed amounts in the list (ePower at $35M in 2025-09-24 and Normax Biomed at $301M in 2022-07-11), indicating a steep top end among otherwise smaller disclosed rounds.
Geographically, the entries cluster heavily around Cork, Ireland, and—when repeated at the city/suburb level—Cork, Cork, Ireland appears alongside Cork, Ireland (e.g., Neurobell and Atlantia Clinical Trials in 2026; Neurobell, Granite Digital, and ePower later). Stage and disclosure are mixed: five entries are explicitly “undisclosed” (Hatch Blue Ltd on 2026-02-10; Zirkulu on 2024-10-17; Vaultree on 2023-09-07; CRAOI on 2023-04-14; Everywhere English on 2023-04-14), and multiple rounds are labeled “Series Unknown” (12 rows).
Most recent rounds
35 shownRelated listings
Frequently asked
What’s the biggest disclosed round in this Cork list, and how does it compare to the rest of the disclosed amounts?
Normax Biomed’s $301M round on 2022-07-11 is the top disclosed amount in the 35-row set, sitting far above the next-largest disclosed amounts such as Amarenco’s $212M (2025-04-15) and ePower’s $35M (2025-09-24).
Are there clear temporal clusters in the most recent Cork rounds?
Yes. Multiple entries concentrate in 2025 alone (e.g., Trustap $10M on 2026-06-10 aside, Granite Digital $10M on 2025-11-19; ePower $35M on 2025-09-24; Amarenco $212M on 2025-04-15), while the older end spans 2020-03-25 to 2020-11-02 (ToDesktop $200K; Solvotrin Therapeutics $7M).
Which disclosure patterns stand out: “undisclosed” amounts or “Series Unknown” rounds?
Five companies show “undisclosed” amounts (Hatch Blue Ltd on 2026-02-10; Zirkulu on 2024-10-17; Vaultree on 2023-09-07; CRAOI on 2023-04-14; Everywhere English on 2023-04-14). Separately, “Series Unknown” appears in 12 rows, including Neurobell (2026-06-29) and Atlantia Clinical Trials (2026-05-19).
How concentrated is the geography—do these rounds mainly stay in Cork, or do they spread across multiple city labels?
Most rows use “Cork, Ireland,” and several specify “Cork, Cork, Ireland” (e.g., Neurobell on 2026-06-29 and Atlantia Clinical Trials on 2026-05-19). There are no non-Cork city geographies shown in the 35 rows.
Is the stage mix dominated by a small set of labels?
No single stage label dominates across the list. There are distinct categories and multiple “Series Unknown” rounds (12 rows), alongside named stages like Seed (e.g., LYQD $1M on 2025-04-13; Giyst $570K on 2024-08-01) and Series B (Workvivo $22M on 2022-06-28; Keelvar $24M on 2022-05-16).
Are there outlier entries worth immediate attention beyond size?
Size is one outlier dimension: Normax Biomed’s $301M (2022-07-11) is far above most other disclosed rounds, while the smallest disclosed amount is Kenzee’s $80K (2023-05-01). A second outlier dimension is disclosure gaps—multiple entries have undisclosed amounts around the same period (e.g., CRAOI on 2023-04-14 and Everywhere English on 2023-04-14).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.